Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Elan E Filler"'
Autor:
Deborah J Springer, R Blake Billmyre, Elan E Filler, Kerstin Voelz, Rhiannon Pursall, Piotr A Mieczkowski, Robert A Larsen, Fred S Dietrich, Robin C May, Scott G Filler, Joseph Heitman
Publikováno v:
PLoS Pathogens, Vol 10, Iss 8, p e1004285 (2014)
Ongoing Cryptococcus gattii outbreaks in the Western United States and Canada illustrate the impact of environmental reservoirs and both clonal and recombining propagation in driving emergence and expansion of microbial pathogens. C. gattii comprises
Externí odkaz:
https://doaj.org/article/06c682fdb6884815a6ded3cfc7358401
Autor:
Luis F. Diaz, Yaoping Liu, Michael R. Yeaman, Elan E. Filler, Norma V. Solis, Scott G. Filler, John E. Edwards
The mechanisms by which Candida glabrata resists host defense peptides and caspofungin are incompletely understood. To identify transcriptional regulators that enable C. glabrata to withstand these classes of stressors, a library of 215 C. glabrata t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f6fc8d1e038b2eeb83a360a3abbb074
Autor:
Norma V. Solis, Yaoping Liu, Luis F. Diaz, Michael R. Yeaman, Ling Wang, Elan E. Filler, Scott G. Filler, John E. Edwards
Publikováno v:
Infect Immun
The mechanisms by which Candida glabrata resists host defense peptides and caspofungin are incompletely understood. To identify transcriptional regulators that enable C. glabrata to withstand these classes of stressors, a library of 215 C. glabrata t
Autor:
Fabrice N. Gravelat, Yukiko Sato, Shane R. Baistrocchi, Hong Liu, Elan E. Filler, P. Lynne Howell, Matthew R. Parsek, Perrin Baker, Donald C. Sheppard, Natalie C. Bamford, Scott G. Filler, Melanie Lehoux, Hanna Ostapska, Brendan D. Snarr, Robert P. Cerone
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America. 114(27)
Galactosaminogalactan and Pel are cationic heteropolysaccharides produced by the opportunistic pathogens Aspergillus fumigatus and Pseudomonas aeruginosa, respectively. These exopolysaccharides both contain 1,4-linked N-acetyl-d-galactosamine and pla
Autor:
Melanie Lehoux, Donald C. Sheppard, Shane R. Baistrocchi, Perrin Baker, Yukiko Sato, Brendan D. Snarr, Robert P. Cerone, P. Lynne Howell, Fabrice N. Gravelat, Scott G. Filler, Hanna Ostapska, Elan E. Filler, Hong Liu, Natalie C. Bamford, Matthew R. Parsek
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, vol 114, iss 27
Snarr, BD; Baker, P; Bamford, NC; Sato, Y; Liu, H; Lehoux, M; et al.(2017). Microbial glycoside hydrolases as antibiofilm agents with cross-kingdom activity. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 114(27), 7124-7129. doi: 10.1073/pnas.1702798114. UCLA: Retrieved from: http://www.escholarship.org/uc/item/1zj434t6
Snarr, BD; Baker, P; Bamford, NC; Sato, Y; Liu, H; Lehoux, M; et al.(2017). Microbial glycoside hydrolases as antibiofilm agents with cross-kingdom activity. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 114(27), 7124-7129. doi: 10.1073/pnas.1702798114. UCLA: Retrieved from: http://www.escholarship.org/uc/item/1zj434t6
Galactosaminogalactan and Pel are cationic heteropolysaccharides produced by the opportunistic pathogens, Aspergillus fumigatus and Pseudomonas aeruginosa, respectively. These exopolysaccharides both contain 1,4-linked N-acetyl-D-galactosamine and pl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c51645eb9226a6af6a71c7589c6c358
Autor:
Scott G. Filler, Robin C. May, Deborah J. Springer, Rhiannon Pursall, R. Blake Billmyre, Kerstin Voelz, Piotr A. Mieczkowski, Robert A. Larsen, Joseph Heitman, Elan E. Filler, Fred S. Dietrich
Publikováno v:
PLoS pathogens, vol 10, iss 8
PLoS Pathogens
Springer, DJ; Billmyre, RB; Filler, EE; Voelz, K; Pursall, R; Mieczkowski, PA; et al.(2014). Cryptococcus gattii VGIII Isolates Causing Infections in HIV/AIDS Patients in Southern California: Identification of the Local Environmental Source as Arboreal. PLOS PATHOGENS, 10(8). doi: 10.1371/journal.ppat.1004285. UCLA: Retrieved from: http://www.escholarship.org/uc/item/1c45c9nv
PLoS Pathogens, Vol 10, Iss 8, p e1004285 (2014)
Springer, D; Billmyre, RB; Filler, E; Voelz, K; Pursall, R; Mieczkowski, PA; et al.(2014). Cryptococcus gattii VGIII isolates causing infections in HIV/AIDS patients in Southern California: identification of the local environmental source as arboreal. MYCOSES, 57, 68-69. UCLA: Retrieved from: http://www.escholarship.org/uc/item/6qd04299
MYCOSES, vol 57
PLoS Pathogens
Springer, DJ; Billmyre, RB; Filler, EE; Voelz, K; Pursall, R; Mieczkowski, PA; et al.(2014). Cryptococcus gattii VGIII Isolates Causing Infections in HIV/AIDS Patients in Southern California: Identification of the Local Environmental Source as Arboreal. PLOS PATHOGENS, 10(8). doi: 10.1371/journal.ppat.1004285. UCLA: Retrieved from: http://www.escholarship.org/uc/item/1c45c9nv
PLoS Pathogens, Vol 10, Iss 8, p e1004285 (2014)
Springer, D; Billmyre, RB; Filler, E; Voelz, K; Pursall, R; Mieczkowski, PA; et al.(2014). Cryptococcus gattii VGIII isolates causing infections in HIV/AIDS patients in Southern California: identification of the local environmental source as arboreal. MYCOSES, 57, 68-69. UCLA: Retrieved from: http://www.escholarship.org/uc/item/6qd04299
MYCOSES, vol 57
Ongoing Cryptococcus gattii outbreaks in the Western United States and Canada illustrate the impact of environmental reservoirs and both clonal and recombining propagation in driving emergence and expansion of microbial pathogens. C. gattii comprises
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3173197ee23133fb4e494900d920a10a
https://escholarship.org/uc/item/1c45c9nv
https://escholarship.org/uc/item/1c45c9nv
Autor:
Cai Y; Titus Family Department of Clinical Pharmacy, Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA, United States.; Jane Anne Nohl Division of Hematology, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States., Ali A; Jane Anne Nohl Division of Hematology, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States., Filler E; Titus Family Department of Clinical Pharmacy, Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA, United States., Bayati R; Titus Family Department of Clinical Pharmacy, Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA, United States., Toma T; Titus Family Department of Clinical Pharmacy, Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA, United States.; Jane Anne Nohl Division of Hematology, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States., Zaki O; Jane Anne Nohl Division of Hematology, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States., Yaghmour G; Jane Anne Nohl Division of Hematology, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States., Ladha A; Jane Anne Nohl Division of Hematology, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States., Woan K; Jane Anne Nohl Division of Hematology, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States., Tam E; Jane Anne Nohl Division of Hematology, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States., Chaudhary PM; Jane Anne Nohl Division of Hematology, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States.
Publikováno v:
Frontiers in oncology [Front Oncol] 2024 Feb 12; Vol. 14, pp. 1329893. Date of Electronic Publication: 2024 Feb 12 (Print Publication: 2024).